GeneriCo

About:

GeneriCo is a generic drug company developing and marketing generic pharmaceuticals in the U.S.

Top Investors: BioGenerator, Missouri Technology Corporation, St. Louis Arch Angels, Billiken Angels Network, Kinsale Capital Partners

Description:

GeneriCo is focused on developing and marketing niche generic pharmaceuticals that have been neglected by mid and large generic companies and also have an embedded drug delivery technology. The combination of neglected, technically challenging formulation, and economic size makes the GeneriCo pipeline not appealing to middle and large competitors, and too complex for tightly focused small generic companies.

Total Funding Amount:

$1.94M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

St Louis, Missouri, United States

Founded Date:

2013-01-01

Contact Email:

Shu.Zhu(AT)genericopharma.com

Founders:

Shu Zhu

Number of Employees:

1-10

Last Funding Date:

2015-07-28

IPO Status:

Private

Industries: